A Wyss Center spin-in transforming epilepsy detection
AI-powered EEG analysis for enhanced epilepsy diagnosis
dEEGtal Insights is a forward-thinking start-up supported by the Wyss Center that is revolutionizing the early detection and diagnosis of epilepsy. The company leverages advanced AI-powered software to deliver precise and timely insights to neurologists, enabling early intervention and better patient outcomes.
The dEEGtal technology that was originally developed at the University of Geneva and the Geneva University Hospitals, addresses current challenges in diagnosing epilepsy by improving its detection accuracy and guiding clinicians toward informed decisions. It also simplifies the EEG analysis process by offering automated medical reporting, automatic slowing detection, and a comprehensive overview of EEG signals.
Accelerate and streamline diagnostic processes, allowing healthcare providers to initiate treatment faster and improve patient care.
Gain deeper insights and unlock advanced analytical capabilities, enabling greater accuracy and confidence in epilepsy diagnosis for better patient outcomes.
Maximize efficiency by reducing the time and effort spent on manual EEG analysis, freeing up valuable resources for more personalized patient care and quicker decision-making.
“dEEGtal Insights’ AI solution has the potential to radically transform epilepsy diagnostics, enabling timely treatment for patients.”
“The Wyss Center didn’t just invest in dEEGtal Insights but in our vision of transforming epilepsy and other neurological diagnosis. Their support goes far beyond funding, providing the strategic insights and network that turn promising AI technology into real-world solutions.”
“dEEGtal Insights represents a major step forward in epilepsy detection, and we are proud to support this innovation. This success also underscores the strength of our collaboration with the Geneva University Hospitals and the University of Geneva.”
